Lawsuit for Investors in Shares of Ligand Pharmaceuticals Inc. (NASDAQ:LGND) in Effort to Recover Losses Filed
An investor, who purchased shares of Ligand Pharmaceuticals Inc. (NASDAQ:LGND), filed a lawsuit in California over alleged Securities Laws violations by Ligand Pharmaceuticals.
View full press release